Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg

NCT03217864 | Unknown

• 1 other identifier: 6843
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Hospitalization at home is booming. It is designed to meet the demands of patients and their families to continue care at home. It partially solves the problem of the lack of places in the "long-term care" structures and allows to respond to a desire of the health policy to reduce the lengths of stay in the hospital. Hospitalization at home is also an alternative in the management of chronic patients. Nevertheless, at the moment a certain number of requests for hospitalization at home remain unsuccessful or their implementation is complicated. In addition, the number of home health care provider has increased significantly in recent years. According to the federation of home health care provider, the number of beneficiaries increased by 1.7% in 4 years. The home health care provider would support 1,200,000 patients per year. The objective of the study is to analyze the factors participating in Implementation of a return home with a Hospitalization at home or a home health care provider during a return home project constructed with the patient and his / her relatives from the services of Oncology, oncology, hematology of the University Hospital of Strasbourg.

Conditions

Cancer

Keywords

Cancer; palliative care; hospitalization at home; home health care provider

Outcome Measures

Primary Outcomes (1)

• Analysis of factors participating in Implementation of a return home with a Hospitalization at home or a home health care provider

  15 days after patient discharge from hospital

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patient over 18 years old for whom an application for Hospitalization at home or with a home health provider is initiated by the Oncology, Oncology or Hematology Department of of the University Hospital of Strasbourg.

You may qualify if:

• Patient over 18 years old
• Patient for whom an application for Hospitalization at home or with a home health provider is initiated by the Oncology, Oncology or Hematology Department of the University Hospital of Strasbourg.

You may not qualify if:

• Refusal to participate in the study

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service Soins Palliatifs

Strasbourg, 67098, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Laurent CALVEL, MD, PhD

  University Hospital, Strasbourg, France

  STUDY DIRECTOR

• Marie DEMEUSE, MD

  University Hospital, Strasbourg, France

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Laurent CALVEL, MD, PhD

CONTACT

33 3 88 12 83 39; laurent.calvel@chru-strasbourg.fr

Marie DEMEUSE, MD

CONTACT

33 3 88 12 83 39; marie.demeuse@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 11, 2017
• First Posted: July 14, 2017
• Study Start: July 12, 2017
• Primary Completion: July 1, 2018
• Study Completion: July 1, 2018
• Last Updated: July 14, 2017

Record last verified: 2017-07

Locations

FR (1)